Molecular mechanisms involved in NAFLD progression

[1]  Raj Vuppalanchi,et al.  Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management , 2009, Hepatology.

[2]  Philippe Giral,et al.  Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. , 2008, Gastroenterology.

[3]  H. Miller,et al.  Safety of Statin Therapy in Patients with Preexisting Liver Disease , 2008, Pharmacotherapy.

[4]  M. Permutt,et al.  Inhibition of Foxo1 Protects Pancreatic Islet β-Cells Against Fatty Acid and Endoplasmic Reticulum Stress–Induced Apoptosis , 2008, Diabetes.

[5]  L. N. Valenti,et al.  Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis , 2007, Diabetes.

[6]  Defeng Wu,et al.  Cytochrome P4502E1 sensitizes to tumor necrosis factor alpha–induced liver injury through activation of mitogen‐activated protein kinases in mice , 2008, Hepatology.

[7]  M. Nishizawa,et al.  Pitavastatin up-regulates the induction of iNOS through enhanced stabilization of its mRNA in pro-inflammatory cytokine-stimulated hepatocytes. , 2008, Nitric oxide : biology and chemistry.

[8]  In-kyu Lee,et al.  Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase–Dependent Regulation of the Orphan Nuclear Receptor SHP , 2008, Diabetes.

[9]  Kun Wook Chung,et al.  Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytess⃞s⃞ The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of three figures. Published, JLR Papers in Press, October 18, 2007. , 2008, Journal of Lipid Research.

[10]  Guoheng Xu,et al.  Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-α in Primary Rat Adipocytes , 2008, Molecular Pharmacology.

[11]  Y. Hui,et al.  Effect of peroxisome proliferator‐activated receptors‐γ and co‐activator‐1α genetic polymorphisms on plasma adiponectin levels and susceptibility of non‐alcoholic fatty liver disease in Chinese people , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[12]  José Rodrigo Pauli,et al.  Statin modulates insulin signaling and insulin resistance in liver and muscle of rats fed a high-fat diet. , 2008, Metabolism: clinical and experimental.

[13]  J. George,et al.  Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets. , 2008, Molecular pharmaceutics.

[14]  M. Cabana,et al.  Probiotic and prebiotic influence beyond the intestinal tract. , 2007, Nutrition reviews.

[15]  P. Iynedjian,et al.  Activation of mammalian target of rapamycin complex 1 and insulin resistance induced by palmitate in hepatocytes. , 2007, Biochemical and biophysical research communications.

[16]  B. Neuschwander‐Tetri,et al.  The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis , 2007, Hepatology.

[17]  K. Cusi,et al.  Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis. , 2007, Journal of hepatology.

[18]  Y. Chawla,et al.  Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. , 2007, Annals of hepatology.

[19]  R. DePinho,et al.  Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. , 2007, Cell metabolism.

[20]  Jongsoon Lee,et al.  The role of GSK3 in glucose homeostasis and the development of insulin resistance. , 2007, Diabetes research and clinical practice.

[21]  K. Kotoh,et al.  Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. , 2007, International journal of molecular medicine.

[22]  A. Fukamizu,et al.  Foxo1 links insulin signaling to C/EBPα and regulates gluconeogenesis during liver development , 2007, The EMBO journal.

[23]  N. Cherrington,et al.  Genes of the antioxidant response undergo upregulation in a rodent model of nonalcoholic steatohepatitis , 2007, Journal of biochemical and molecular toxicology.

[24]  J. Hoofnagle,et al.  The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis , 2007, Hepatology.

[25]  Peter W Angus,et al.  Liver fibrosis: a balance of ACEs? , 2007, Clinical science.

[26]  E. Distrutti,et al.  Targeting farnesoid X receptor for liver and metabolic disorders. , 2007, Trends in molecular medicine.

[27]  Jordi Muntané,et al.  Mecanismos de lesión hepatocelular , 2007 .

[28]  M. Başkol,et al.  Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis. , 2007, Clinical biochemistry.

[29]  M. Holmqvist,et al.  Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study. , 2007, Journal of hepatology.

[30]  Y. Zick,et al.  Common Inhibitory Serine Sites Phosphorylated by IRS-1 Kinases, Triggered by Insulin and Inducers of Insulin Resistance* , 2007, Journal of Biological Chemistry.

[31]  G. Tarantino,et al.  A prospective study of acute drug‐induced liver injury in patients suffering from non‐alcoholic fatty liver disease , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[32]  S. McCall,et al.  Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis , 2007, Hepatology.

[33]  Hui-yu Liu,et al.  Prolonged Treatment of Primary Hepatocytes with Oleate Induces Insulin Resistance through p38 Mitogen-activated Protein Kinase* , 2007, Journal of Biological Chemistry.

[34]  T. Saibara,et al.  The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population. , 2007, Journal of hepatology.

[35]  R. Ahima,et al.  Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide. , 2007, Gastroenterology.

[36]  D. Adams,et al.  The Role of Cytokines and Chemokines in the Development of Steatohepatitis , 2007, Seminars in liver disease.

[37]  M. C. Archer,et al.  Celecoxib Decreases Fatty Acid Synthase Expression via Down-Regulation of c-Jun N-Terminal Kinase-1 , 2007, Experimental biology and medicine.

[38]  Hirokazu Takahashi,et al.  Telmisartan, An Angiotensin II Type 1 Receptor Blocker, Controls Progress of Nonalcoholic Steatohepatitis in Rats , 2007, Digestive Diseases and Sciences.

[39]  R. Ersoy,et al.  Effects of vitamin E treatment on peroxisome proliferator‐activated receptor‐α expression and insulin resistance in patients with non‐alcoholic steatohepatitis: results of a pilot study , 2007 .

[40]  C. Corporeau,et al.  Long-chain n-3 polyunsaturated fatty acids dissociate phosphorylation of Akt from phosphatidylinositol 3'-kinase activity in rats. , 2007, American journal of physiology. Endocrinology and metabolism.

[41]  K. Nakao,et al.  Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes. , 2007, American journal of physiology. Endocrinology and metabolism.

[42]  G. Shulman,et al.  Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease , 2007 .

[43]  C. McClain,et al.  Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. , 2007, The Journal of nutritional biochemistry.

[44]  R. Merriman,et al.  Medical treatment of non-alcoholic steatohepatitis. , 2007, Clinics in liver disease.

[45]  M. Permutt,et al.  Inhibition of Foxo1 Protects Pancreatic Islet ® -Cells Against Fatty Acid and ER-Stress Induced Apoptosis , 2007 .

[46]  R. Ersoy,et al.  Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study. , 2007, Internal medicine journal.

[47]  A. Federico,et al.  The Effect of a Silybin-Vitamin E-Phospholipid Complex on Nonalcoholic Fatty Liver Disease: A Pilot Study , 2007, Digestive Diseases and Sciences.

[48]  A. Aljada,et al.  Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects , 2007, Diabetologia.

[49]  M. Wright.  The impact of pregnane X receptor activation on liver fibrosis. , 2006, Biochemical Society transactions.

[50]  A. Gerbes,et al.  Role of Kupffer cells in host defense and liver disease , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[51]  A. Diehl,et al.  PPARγ Agonists Prevent TGFβ1/Smad3-Signaling in Human Hepatic Stellate Cells , 2006 .

[52]  J. Sicklick,et al.  Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice , 2006, Hepatology.

[53]  L. Malaguarnera,et al.  Chitotriosidase: the yin and yang , 2006, Cellular and Molecular Life Sciences CMLS.

[54]  M. Quon,et al.  PKCδ-mediated IRS-1 Ser24 phosphorylation negatively regulates IRS-1 function , 2006 .

[55]  A. Fukamizu,et al.  The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity. , 2006, The Journal of clinical investigation.

[56]  G. Svegliati-Baroni,et al.  A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. , 2006, The American journal of pathology.

[57]  R. Marco,et al.  Potential Role of Chitotriosidase Gene in Nonalcoholic Fatty Liver Disease Evolution , 2006, The American Journal of Gastroenterology.

[58]  J. Fernandez-Checa,et al.  Mitochondrial glutathione: Hepatocellular survival–death switch , 2006, Journal of gastroenterology and hepatology.

[59]  M. Karin,et al.  Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[60]  F. Nicoletti,et al.  Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease , 2006, Gut.

[61]  G. Shulman,et al.  Targeting Foxo1 in Mice Using Antisense Oligonucleotide Improves Hepatic and Peripheral Insulin Action , 2006, Diabetes.

[62]  N. Chalasani,et al.  Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study. , 2006, The Journal of clinical endocrinology and metabolism.

[63]  J. Perkins.  Saying “yes” to obese living liver donors: Short‐term intensive treatment for donors with hepatic steatosis in living‐donor liver transplantation. Nakamuta M, Morizono S, Soejiima Y, Yoshizumi T, Aishima S, Takasugi S, et al. Transplantation 2005;80:608–612. , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[64]  David A. Brenner,et al.  Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways , 2006 .

[65]  Jawed Alam,et al.  Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. , 2006, Physiological reviews.

[66]  Jeanne M Clark,et al.  The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults , 2006, Journal of clinical gastroenterology.

[67]  A. McCullough.  Pathophysiology of nonalcoholic steatohepatitis. , 2006, Journal of clinical gastroenterology.

[68]  Jacqueline Capeau,et al.  Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.

[69]  T. Okumura,et al.  Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet. , 2006, Biochemical and biophysical research communications.

[70]  C. McClain,et al.  Glutathione‐enhancing agents protect against steatohepatitis in a dietary model , 2006, Journal of biochemical and molecular toxicology.

[71]  D. Pessayre,et al.  Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. , 2006, Mitochondrion.

[72]  M. Czaja,et al.  Jnk1 but not jnk2 promotes the development of steatohepatitis in mice , 2006, Hepatology.

[73]  M. Quon,et al.  PKCdelta-mediated IRS-1 Ser24 phosphorylation negatively regulates IRS-1 function. , 2006, Biochemical and biophysical research communications.

[74]  C. Day.  From fat to inflammation. , 2006, Gastroenterology.

[75]  R. Schwabe,et al.  Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[76]  P. Portincasa,et al.  Current pharmacological treatment of nonalcoholic fatty liver. , 2006, Current medicinal chemistry.

[77]  E. Novo,et al.  Nrf1 gene expression in the liver: a single gene linking oxidative stress to NAFLD, NASH and hepatic tumours. , 2005, Journal of hepatology.

[78]  A. di Sario,et al.  Hepatoprotective and antifibrotic effect of a new silybin-phosphatidylcholine-Vitamin E complex in rats. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[79]  G. Marchesini,et al.  Insulin resistance: A metabolic pathway to chronic liver disease , 2005, Hepatology.

[80]  B. Dahiyat,et al.  JNK and Tumor Necrosis Factor-α Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes* , 2005, Journal of Biological Chemistry.

[81]  B. Sharma,et al.  Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH). , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[82]  C. Kahn,et al.  Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[83]  A. Diehl.  Lessons from animal models of NASH. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[84]  K. Lindor,et al.  Nonalcoholic fatty liver disease , 2005, Canadian Medical Association Journal.

[85]  A. Scuto,et al.  Action of prolactin, IFN-γ, TNF-α and LPS on heme oxygenase-1 expression and VEGF release in human monocytes/macrophages , 2005 .

[86]  Shuli Wang,et al.  Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD) , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[87]  C. De Simone,et al.  Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases , 2005, Journal of clinical gastroenterology.

[88]  B. Schreiber,et al.  PPARγ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes , 2005 .

[89]  L. N. Valenti,et al.  Nuclear Trapping of the Forkhead Transcription Factor FoxO1 via Sirt-dependent Deacetylation Promotes Expression of Glucogenetic Genes* , 2005, Journal of Biological Chemistry.

[90]  A. Scuto,et al.  Effect of interferon-γ, interleukin-10, lipopolysaccharide and tumor necrosis factor-α on chitotriosidase synthesis in human macrophages , 2005 .

[91]  K. Nakao,et al.  [Role of PPARs in the pathophysiology of nonalcoholoic fatty liver disease]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[92]  M. Malaguarnera,et al.  Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. , 2005, Journal of hepatology.

[93]  M. Czaja,et al.  Hepatocyte CYP2E1 Overexpression and Steatohepatitis Lead to Impaired Hepatic Insulin Signaling* , 2005, Journal of Biological Chemistry.

[94]  Candy S. Lee,et al.  Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[95]  E. Ferrannini,et al.  Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms , 2005, Diabetologia.

[96]  P. Prada,et al.  Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. , 2005, Endocrinology.

[97]  A. Cederbaum,et al.  Protein Kinase C Signaling as a Survival Pathway against CYP2E1-Derived Oxidative Stress and Toxicity in HepG2 Cells , 2005, Journal of Pharmacology and Experimental Therapeutics.

[98]  G. Rice,et al.  Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro. , 2005, Endocrinology.

[99]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.

[100]  A. Hevener,et al.  IKK-β links inflammation to obesity-induced insulin resistance , 2005, Nature Medicine.

[101]  A. Scuto,et al.  Action of prolactin, IFN-gamma, TNF-alpha and LPS on heme oxygenase-1 expression and VEGF release in human monocytes/macrophages. , 2005, International immunopharmacology.

[102]  A. Scuto,et al.  Effect of interferon-gamma, interleukin-10, lipopolysaccharide and tumor necrosis factor-alpha on chitotriosidase synthesis in human macrophages. , 2005, Clinical chemistry and laboratory medicine.

[103]  K. Kotoh,et al.  Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. , 2005, International journal of molecular medicine.

[104]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. , 2005, Nature medicine.

[105]  B. Schreiber,et al.  PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. , 2005, American journal of physiology. Endocrinology and metabolism.

[106]  C. McClain,et al.  S‐adenosylhomocysteine sensitizes to TNF‐α hepatotoxicity in mice and liver cells: A possible etiological factor in alcoholic liver disease , 2004, Hepatology.

[107]  H. Cortez‐Pinto,et al.  Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients , 2004, The American Journal of Gastroenterology.

[108]  A. Lonardo,et al.  Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver , 2004, Hepatology.

[109]  K. Iizuka,et al.  Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[110]  T. Saibara,et al.  Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. , 2004, Journal of hepatology.

[111]  K. Lindor,et al.  Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction , 2004, Hepatology.

[112]  R. Rodrigo,et al.  Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. , 2004, Clinical science.

[113]  A. Sonsuz,et al.  N‐Acetylcysteine in The Treatment Of Non‐Alcoholic Steatohepatitis , 2003, Journal of gastroenterology and hepatology.

[114]  Jay D. Horton,et al.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[115]  Seungho Wang,et al.  Temporal and spatial assembly of lipid droplet-associated proteins in 3T3-L1 preadipocytes , 2003, Histochemistry and Cell Biology.

[116]  M. Reitman,et al.  Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass* , 2003, Journal of Biological Chemistry.

[117]  R. Potter,et al.  The heme oxygenase system: its role in liver inflammation. , 2003, Current drug targets. Cardiovascular & haematological disorders.

[118]  S. Wakil,et al.  Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[119]  M. Koruk,et al.  Serum Lipids, Lipoproteins and Apolipoproteins Levels in Patients With Nonalcoholic Steatohepatitis , 2003, Journal of clinical gastroenterology.

[120]  Z. Dong,et al.  Aspirin Inhibits Serine Phosphorylation of Insulin Receptor Substrate 1 in Tumor Necrosis Factor-treated Cells through Targeting Multiple Serine Kinases* , 2003, Journal of Biological Chemistry.

[121]  A. Moser,et al.  Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease , 2003, Hepatology.

[122]  M. White,et al.  c-Jun N-terminal Kinase (JNK) Mediates Feedback Inhibition of the Insulin Signaling Cascade* , 2003, The Journal of Biological Chemistry.

[123]  Jianping Ye,et al.  Serine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor κB Kinase Complex* 210 , 2002, The Journal of Biological Chemistry.

[124]  N. Abraham,et al.  Significance of heme oxygenase in prolactin-mediated cell proliferation and angiogenesis in human endothelial cells. , 2002, International journal of molecular medicine.

[125]  Naresh Kumar,et al.  Metformin enhances insulin signalling in insulin‐dependent and ‐independent pathways in insulin resistant muscle cells , 2002, British journal of pharmacology.

[126]  I. G. Fantus,et al.  Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-δ , 2002 .

[127]  M. White,et al.  IRS proteins and the common path to diabetes. , 2002, American journal of physiology. Endocrinology and metabolism.

[128]  R. Sears,et al.  Insulin Inhibits Hepatocellular Glucose Production by Utilizing Liver-enriched Transcriptional Inhibitory Protein to Disrupt the Association of CREB-binding Protein and RNA Polymerase II with the Phosphoenolpyruvate Carboxykinase Gene Promoter* , 2002, The Journal of Biological Chemistry.

[129]  A. Lonardo,et al.  Apolipoprotein synthesis in nonalcoholic steatohepatitis , 2002, Hepatology.

[130]  M. Weltman,et al.  HFE mutations, hepatic iron, and fibrosis: Ethnic‐specific association of NASH with C282Y but not with fibrotic severity , 2002, Hepatology.

[131]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[132]  H. Yamashita,et al.  Mechanism for Fatty Acid “Sparing” Effect on Glucose-induced Transcription , 2002, The Journal of Biological Chemistry.

[133]  R. Karim,et al.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.

[134]  I. G. Fantus,et al.  Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta. , 2002, American journal of physiology. Endocrinology and metabolism.

[135]  J. Maher.  Alcoholic steatosis and steatohepatitis. , 2002, Seminars in gastrointestinal disease.

[136]  Jianping Ye,et al.  Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. , 2002, The Journal of biological chemistry.

[137]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[138]  I. Leclercq,et al.  Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[139]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[140]  G. Sesti,et al.  Defects of the insulin receptor substrate (IRS) system in human metabolic disorders , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[141]  M. Sakurai,et al.  A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[142]  Shelly C. Lu,et al.  Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[143]  J. Clore,et al.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.

[144]  Martin M. Matzuk,et al.  Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2 , 2001, Science.

[145]  M. Cheung,et al.  GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex. , 2001, Journal of lipid research.

[146]  B. Jude,et al.  PPARα Agonists Inhibit Tissue Factor Expression in Human Monocytes and Macrophages , 2001 .

[147]  R. Rozen,et al.  Polymorphisms in the Methylenetetrahydrofolate Reductase Gene , 2001, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[148]  J. Reddy,et al.  Peroxisomal β-Oxidation and Steatohepatitis , 2001 .

[149]  E. Brunt.  Nonalcoholic Steatohepatitis: Definition and Pathology , 2001, Seminars in liver disease.

[150]  R. Rozen,et al.  Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences. , 2001, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[151]  M. Rao,et al.  Peroxisomal beta-oxidation and steatohepatitis. , 2001, Seminars in liver disease.

[152]  D. Pessayre,et al.  Mitochondria in Steatohepatitis , 2001, Seminars in liver disease.

[153]  G. Marchesini,et al.  Synthesis of glutathione in response to methionine load in control subjects and in patients with cirrhosis. , 2000, Metabolism: clinical and experimental.

[154]  M. Tirmenstein,et al.  Glutathione depletion and the production of reactive oxygen species in isolated hepatocyte suspensions. , 2000, Chemico-biological interactions.

[155]  Z. Halpern,et al.  NASH: Can we iron out the pathogenesis? , 2000, Gastroenterology.

[156]  I. Leclercq,et al.  CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. , 2000, The Journal of clinical investigation.

[157]  M. Kasuga,et al.  Role of SNAP23 in Insulin-induced Translocation of GLUT4 in 3T3-L1 Adipocytes , 2000, The Journal of Biological Chemistry.

[158]  S. Chirala,et al.  The subcellular localization of acetyl-CoA carboxylase 2. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[159]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[160]  M. Suematsu,et al.  The heme oxygenase–carbon monoxide system: u regulator of hepatobiliary function , 2000, Hepatology.

[161]  Jay D. Horton,et al.  Increased Levels of Nuclear SREBP-1c Associated with Fatty Livers in Two Mouse Models of Diabetes Mellitus* , 1999, The Journal of Biological Chemistry.

[162]  B. Spiegelman,et al.  Regulation of Peroxisome Proliferator-Activated Receptor γ Expression by Adipocyte Differentiation and Determination Factor 1/Sterol Regulatory Element Binding Protein 1: Implications for Adipocyte Differentiation and Metabolism , 1999, Molecular and Cellular Biology.

[163]  G. Serrero,et al.  Adipose Differentiation Related Protein (ADRP) Expressed in Transfected COS-7 Cells Selectively Stimulates Long Chain Fatty Acid Uptake* , 1999, The Journal of Biological Chemistry.

[164]  F. Folli,et al.  Insulin and insulin‐like growth factor‐1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: Differential effects on signal transduction pathways , 1999, Hepatology.

[165]  J. Björkegren,et al.  Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. , 1999, The Journal of clinical investigation.

[166]  C. Kahn,et al.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. , 1999, The Journal of clinical investigation.

[167]  C. D. de Vries,et al.  Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[168]  V. P. Chacko,et al.  Obesity Induces Expression of Uncoupling Protein-2 in Hepatocytes and Promotes Liver ATP Depletion* , 1999, The Journal of Biological Chemistry.

[169]  L. Olson,et al.  Mouse glycosylphosphatidylinositol-specific phospholipase D (Gpld1) characterization , 1998, Mammalian Genome.

[170]  D. Accili,et al.  Evidence That IRS-2 Phosphorylation Is Required for Insulin Action in Hepatocytes* , 1998, The Journal of Biological Chemistry.

[171]  C. Fan,et al.  Steatohepatitis, Spontaneous Peroxisome Proliferation and Liver Tumors in Mice Lacking Peroxisomal Fatty Acyl-CoA Oxidase , 1998, The Journal of Biological Chemistry.

[172]  W. Fiers,et al.  Regulation of microsomal triglyceride transfer protein mRNA expression by endotoxin and cytokines. , 1998, Journal of lipid research.

[173]  B. Spiegelman,et al.  ADD1/SREBP1 activates PPARγ through the production of endogenous ligand , 1998 .

[174]  M. Ingelman-Sundberg,et al.  Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis , 1998, Hepatology.

[175]  B. Spiegelman,et al.  ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[176]  N. Kaplowitz,et al.  Mitochondrial glutathione: importance and transport. , 1998, Seminars in liver disease.

[177]  F. Corrales,et al.  Interaction of liver methionine adenosyltransferase with hydroxyl radical , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[178]  G. Poli,et al.  The lipid peroxidation end product 4‐hydroxy‐2,3‐nonenal up‐regulates transforming growth factor β1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis 1 , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[179]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[180]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[181]  A. Varki,et al.  Does DG42 synthesize hyaluronan or chitin?: A controversy about oligosaccharides in vertebrate development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[182]  C. Trautwein,et al.  Stimulation of collagen α1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: A link to tissue fibrosis? , 1994, Hepatology.

[183]  W. Fiers,et al.  Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. , 1992, The Journal of biological chemistry.

[184]  S. Friedman.  Cellular Sources of Collagen and Regulation of Collagen Production in Liver , 1990, Seminars in liver disease.

[185]  M. Maines.  Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[186]  J. Mato,et al.  S‐adenosyl‐L‐methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis , 1988, Hepatology.

[187]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.